Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.

Anne CallejaSeongseok YunChimène MoreilhonJean Michel KarsentiLauris GastaudLionel MannoneRami KomrokjiNajla Al AliBérangère Dadone-MontaudieGuillaume RobertPatrick AubergerSophie RaynaudDavid A SallmanThomas Cluzeau

Published in: European journal of haematology (2020)

We confirmed that the molecular complexity of t-MNs and that the follow-up of clonal selection during AZA treatment could be useful to define treatment combination.

Keyphrases

acute myeloid leukemia
stem cells
combination therapy
bone marrow
drug induced